Reported Mar 15, 2023 · Terminated

Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or…

Sagent Pharmaceuticals Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Sagent Pharmaceuticals Inc · 1901 N Roselle Rd Ste 450 · Schaumburg, IL · 60195-3194

Is this the product you have?

  • Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd
  • forSagent Pharmaceuticals, Schaumburg, IL 60195; Made in India
  • NDC carton25021-404-01
Lot codes and dates
    • Lot#: WP201
    • Exp 2/2024
Amount recalled
28,875 vials

Where it was sold

  • Nationwide

Why it was recalled

Labeling: Not elsewhere classified

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Sagent Pharmaceuticals Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated May 19, 2026 · Data as of Sep 19, 5:55 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.